Octapharma AG - Company Profile
Powered by 
All the sales intelligence you need on Octapharma AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Octapharma AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Octapharma AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Octapharma AG patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| DK3458085T3 | Application | GLYKOSYLERET VWF-FUSIONSPROTEINER MED FORBEDRET FARMAKOKINETIK | A61K38/00; A61K38/37; A61K47/64; A61P7/04; C07K14/745; C07K14/755; C07K2319/00; C07K2319/02; C07K2319/20; C07K2319/31; C07K2319/35; C12N15/62 | January 30, 2023 |
| BR122022006547B1 | Grant | MÉTODOS DE FABRICAÇÃO DE UMA PELÍCULA À BASE DE PLASMA FLEXÍVEL, E PELÍCULAS À BASE DE PLASMA FLEXÍVEL | A61L15/38; A61L15/40; A61L15/42; A61L15/44; A61L2300/254; A61L2300/418; A61L2400/04; A61L31/005; A61L31/047; A61L31/14; A61L31/16 | December 13, 2022 |
| EP3458085B1 | Grant | GLYKOSYLIERTE VWF-FUSIONSPROTEINE MIT VERBESSERTER PHARMAKOKINETIK | A61K38/00; A61K38/37; A61K47/64; A61P7/04; C07K14/745; C07K14/755; C07K2319/00; C07K2319/02; C07K2319/20; C07K2319/31; C07K2319/35; C12N15/62 | December 07, 2022 |
| EP3701973B1 | Grant | PLASMABASIERTE FOLIEN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON | A61L15/38; A61L15/40; A61L15/42; A61L15/44; A61L2300/254; A61L2300/418; A61L2400/04; A61L31/005; A61L31/047; A61L31/14; A61L31/16 | October 26, 2022 |
| US20220305089A1 | Application | STABILIZING BUFFER FOR FACTOR VIII AND VWF | A61K38/37; A61K47/02; A61K47/183; A61K47/26; A61K47/42; A61K9/08; A61K9/19 | September 29, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer